Thomas Schall, President & CEO, Director at ChemoCentryx, holds 52.88K shares in Immuneering (Ticker: IMRX), holds 0.00 shares in ChemoCentryx (Ticker: CCXI). Most recently, Thomas Schall Bought ― shares of Immuneering on Jun 30, 2025 for an estimated value of 34.77K.
What is the percentage of profitable transactions made by Thomas Schall?
The percentage of profitable transactions made by Thomas Schall is 67%.
What is the average return per transaction made by Thomas Schall?
The average return per transaction made by Thomas Schall is 12.70%.
What stocks does Thomas Schall hold?
Thomas Schall holds: CCXI, IMRX stocks.
What was Thomas Schall’s latest transaction?
Thomas Schall latest transaction was an Informative Buy of $34.77K.
What was Thomas Schall's most profitable transaction?
Thomas Schall’s most profitable transaction was an Informative Buy of IMRX stock on June 18, 2025. The return on the trade was 49.00%.
What is Thomas Schall's role in ChemoCentryx?
Thomas Schall's role in ChemoCentryx is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.